MLSS
MILESTONE SCIENTIFIC INC.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- E Apr 21 Offering: Milestone Scientific Inc. Completes $2.15 Million Private…
- E May 27 FDA: Milestone Scientific Highlights Growing Clinical Adoption…
- R Jun 2 Milestone Scientific filed a resale S-3 shelf registration covering…
- R Jun 10 The SEC declared effective Milestone Scientific's S-3 shelf registra…
- X Jul 31 Short interest falls 31.8% to 113.5K
- X Aug 14 Short interest jumps 84.5% to 209.4K
- X Aug 31 Short interest falls 62.5% to 78.6K
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 2 added (0 new), 3 trimmed or exited.
- EstimatesFLAT
Current-quarter EPS estimate −$0.010 → −$0.010 over 90 days.
- TrendDOWNTREND
27% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| VANGUARD FIDUCIARY TRUST CO | ADD | $149.1K |
| STATE STREET CORP | ADD | $85.0K |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $18.1K |
| UBS Group AG | NEAR_EXIT | $2.8K |
| MORGAN STANLEY | TRIM | $967.00 |
| CITIGROUP INC | NEAR_EXIT | — |
| UBS Group AG | TRIM | $18.0K |
| UBS Group AG | DOUBLED | $26.2K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Nov 2025Price is below the lowest target. Median implies +317%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 20, 2025 | Benchmark MAINTAIN | Speculative Buy |
| Nov 20, 2024 | Benchmark REITERATE | Speculative Buy |
| Oct 10, 2024 | Benchmark INITIATE | Speculative Buy |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.01 | -$0.01–-$0.01 | +0.0% | $2.4M |
| Next Q | -$0.01 | -$0.01–-$0.01 | +0.0% | $2.6M |
| Current FY | -$0.04 | -$0.04–-$0.04 | -14.3% | $10.0M |
| Next FY | -$0.04 | -$0.04–-$0.03 | +0.0% | $11.4M |
Short side
FINRA· Oct 15, 2026SecBot reports
11 filings · 2 press releases · 0 bullish · 3 bearish · 8 neutral- BEARISH EFFECTSep 29, 2026
The SEC declared effective Milestone Scientific's S-3 shelf registration (File No. 333-298804) on…
The shelf is now live — watch for a prospectus supplement or 424B filing indicating an actual takedown. Any offering announcement would crystallize dilution and likely pressure the stock. Monitor…
- NEUTRAL S-3/ASep 18, 2026
Milestone Scientific filed Amendment No. 1 to its S-3 shelf registration statement to correct a…
This is a purely administrative filing with no trading implications. Monitor for future prospectus supplements that would indicate actual securities sales under the shelf, which would trigger…
- NEUTRAL PRESS-RELEASEAug 14, 2026
Milestone Scientific reported Q2 2026 revenue of $2.8M (+22% YoY), in line with consensus, and EPS…
The in-line quarter and reaffirmed guidance suggest limited near-term catalyst. Monitor Q3 results for medical segment traction and whether the non-recurring international orders create a sequential…
- NEUTRAL 8-KJul 31, 2026
Milestone Scientific filed an 8-K reporting the re-election of two directors (Kelly Ulto and Greg…
Monitor future 10-Q filings for share issuances under the expanded equity plan, which could indicate management's use of equity compensation. The authorized share increase is modest and provides…
All MLSS filing & press-release reports (13)
- EFFECT reportSep 29, 2026
- S-3/A reportSep 18, 2026
- PRESS-RELEASE reportAug 14, 2026
- 8-K reportJul 31, 2026
- 8-K reportJul 29, 2026
- EFFECT reportJun 10, 2026
- S-3 reportJun 2, 2026
- PRESS-RELEASE reportMay 27, 2026
- PRESS-RELEASE reportMay 14, 2026
- 8-K reportMay 6, 2026
- 8-K reportMay 6, 2026
- 8-K reportApr 21, 2026
- PRESS-RELEASE reportApr 21, 2026